TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — Gross Profit

Annual figures by fiscal year, from SEC filings.

2010: $3.68M2011: $4.35M2012: $3.48M2013: $3.64M2014: $4.41M2015: $5.93M2016: $5.57M2017: $3.29M2018: $4.69M2019: $3.10M2020: $1.44M2021: $2.92M2022: $13.97M2023: $8.27M$8.27M
2010Gross Profit (USD)2023
Fiscal YearGross ProfitChange YoY
2023$8.27M-40.8%
2022$13.97M+379.4%
2021$2.92M+102.3%
2020$1.44M-53.6%
2019$3.10M-33.8%
2018$4.69M+42.4%
2017$3.29M-40.9%
2016$5.57M-6.1%
2015$5.93M+34.5%
2014$4.41M+21.0%
2013$3.64M+4.6%
2012$3.48M-20.1%
2011$4.35M+18.3%
2010$3.68M—